Nowadays, the comprehensive treatment for inflammatory breast cancer has been widely accepted, but there is still a lack of general agreement on the diagnostic and treatment criterion for this disease in our country. Some improvements in the overall survival of this disease are achieved by treatments such as neoadjuvant chemotherapy, surgery, and postoperative chemotherapy or radiotherapy as well as molecularly targeted therapy. This paper addresses the recent progress in diagnosis and treatment of inflammatory breast cancer.